Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prometheus Biosciences Inc (RXDX)

Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,558,772
  • Shares Outstanding, K 47,813
  • Annual Sales, $ 6,810 K
  • Annual Income, $ -141,750 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.49
  • Price/Sales 1,402.58
  • Price/Cash Flow N/A
  • Price/Book 13.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.52
  • Most Recent Earnings $-0.86 on 05/09/23
  • Next Earnings Date 08/10/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.91
  • Number of Estimates 5
  • High Estimate -0.81
  • Low Estimate -0.99
  • Prior Year -0.86
  • Growth Rate Est. (year over year) -5.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
189.76 +5.35%
on 05/16/23
199.98 -0.03%
on 06/15/23
+5.49 (+2.82%)
since 05/15/23
3-Month
104.55 +91.22%
on 03/30/23
199.98 -0.03%
on 06/15/23
+84.34 (+72.97%)
since 03/15/23
52-Week
23.27 +759.13%
on 06/16/22
199.98 -0.03%
on 06/15/23
+174.70 (+692.70%)
since 06/15/22

Most Recent Stories

More News
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 46.85 (-0.23%)
KNSA : 20.56 (-0.15%)
ACAD : 16.92 (+0.30%)
HRMY : 34.83 (+1.60%)
AMPH : 38.76 (-0.97%)
INCY : 68.94 (+0.15%)
AGEN : 2.76 (-2.47%)
NVS : 97.50 (+0.40%)
PFE : 26.39 (+0.11%)
SGEN : 228.74 (-0.07%)
MRK : 98.82 (+0.79%)
RXDX : 199.92 (+0.09%)
Why Shares of Exscientia Jumped on Wednesday

The company may be riding the wave of an AI healthcare boom.

NVDA : 138.20 (+2.60%)
SNY : 47.96 (+0.52%)
RXDX : 199.92 (+0.09%)
BYM : 10.79 (-0.64%)
COMP : 6.01 (-3.53%)
EXAI : 4.84 (+3.20%)
Why Shares of Ventyx Biosciences Rose Monday

The company has several promising autoimmune therapies.

DICE : 47.55 (+0.06%)
RXDX : 199.92 (+0.09%)
MRK : 98.82 (+0.79%)
LLY : 788.19 (+2.66%)
VTYX : 2.29 (+2.23%)
Is Merck Stock a Top Buy Right Now?

The drugmaker is still a work in progress.

RXDX : 199.92 (+0.09%)
MRK : 98.82 (+0.79%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXDX, RADI, FOCS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RXDX : 199.92 (+0.09%)
RADI : 15.00 (+0.20%)
FOCS : 52.99 (-0.02%)
Is Bristol Myers Squibb a Top Dividend Stock?

Its hefty yield isn't the only reason to consider buying this top pharma stock.

BMY : 57.29 (-0.07%)
RXDX : 199.92 (+0.09%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXDX, MDWT, RUTH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RXDX : 199.92 (+0.09%)
MDWT : 26.99 (unch)
RUTH : 21.49 (+0.05%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTV, RXDX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MNTV : 9.45 (unch)
RXDX : 199.92 (+0.09%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ISEE, MDWT, RXDX, UNVR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ISEE : 39.95 (+0.38%)
MDWT : 26.99 (unch)
RXDX : 199.92 (+0.09%)
UNVR : 36.14 (+0.47%)
Merck Makes a Bold Move That Could Transform Its Business

It's a risky deal for Merck, but it could pay off significantly.

AET.LN : 45.800 (+1.33%)
AGN.AX : 0.610 (+0.83%)
PFE : 26.39 (+0.11%)
MRK : 98.82 (+0.79%)
RXDX : 199.92 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 200.45
2nd Resistance Point 200.21
1st Resistance Point 200.07
Last Price 199.92
1st Support Level 199.69
2nd Support Level 199.45
3rd Support Level 199.31

See More

52-Week High 199.98
Last Price 199.92
Fibonacci 61.8% 132.48
Fibonacci 50% 111.63
Fibonacci 38.2% 90.77
52-Week Low 23.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar